Free Trial
NASDAQ:ZIVO

ZIVO Bioscience (ZIVO) Stock Price, News & Analysis

ZIVO Bioscience logo
$11.99 0.00 (0.00%)
As of 07/2/2025 11:07 AM Eastern

About ZIVO Bioscience Stock (NASDAQ:ZIVO)

Key Stats

Today's Range
$10.00
$11.99
50-Day Range
$11.99
$18.80
52-Week Range
$5.80
$22.15
Volume
2,169 shs
Average Volume
997 shs
Market Capitalization
$45.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ZIVO Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

ZIVO MarketRank™: 

ZIVO Bioscience scored higher than 5% of companies evaluated by MarketBeat, and ranked 932nd out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for ZIVO Bioscience.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ZIVO Bioscience is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ZIVO Bioscience is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about ZIVO Bioscience's valuation and earnings.
  • Percentage of Shares Shorted

    1.77% of the float of ZIVO Bioscience has been sold short.
  • Short Interest Ratio / Days to Cover

    ZIVO Bioscience has a short interest ratio ("days to cover") of 42.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in ZIVO Bioscience has recently decreased by 0.77%, indicating that investor sentiment is improving.
  • Dividend Yield

    ZIVO Bioscience does not currently pay a dividend.

  • Dividend Growth

    ZIVO Bioscience does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.77% of the float of ZIVO Bioscience has been sold short.
  • Short Interest Ratio / Days to Cover

    ZIVO Bioscience has a short interest ratio ("days to cover") of 42.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in ZIVO Bioscience has recently decreased by 0.77%, indicating that investor sentiment is improving.
  • News Sentiment

    ZIVO Bioscience has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.
  • Insider Buying vs. Insider Selling

    In the past three months, ZIVO Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    21.50% of the stock of ZIVO Bioscience is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 12.83% of the stock of ZIVO Bioscience is held by institutions.

  • Read more about ZIVO Bioscience's insider trading history.
Receive ZIVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

ZIVO Stock News Headlines

Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
See More Headlines

ZIVO Stock Analysis - Frequently Asked Questions

ZIVO Bioscience's stock was trading at $21.50 on January 1st, 2025. Since then, ZIVO shares have decreased by 44.2% and is now trading at $11.99.
View the best growth stocks for 2025 here
.

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) announced its earnings results on Monday, May, 11th. The biotechnology company reported ($0.06) EPS for the quarter. The biotechnology company had revenue of $0.02 million for the quarter.

ZIVO Bioscience's stock reverse split on Friday, October 27th 2023.The 1-6 reverse split was announced on Friday, October 27th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, October 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ZIVO Bioscience investors own include Canopy Growth (CGC), Meta Platforms (META), OPKO Health (OPK), Johnson & Johnson (JNJ), ACADIA Pharmaceuticals (ACAD), ARAVIVE (ARAV) and Alibaba Group (BABA).

Company Calendar

Last Earnings
5/11/2020
Today
7/03/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZIVO
Previous Symbol
OTCMKTS:HEPI
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.78 million
Pretax Margin
-17,113.75%

Debt

Sales & Book Value

Annual Sales
$15.85 thousand
Price / Cash Flow
N/A
Book Value
($0.81) per share
Price / Book
-14.80

Miscellaneous

Free Float
2,911,000
Market Cap
$45.72 million
Optionable
Not Optionable
Beta
0.02

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ZIVO) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners